Daiko Wakita
Chugai Pharma (United States)(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Cancer Cells and Metastasis, Chemical Reactions and Isotopes
Most-Cited Works
- → Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy(2010)241 cited
- → Tumor‐infiltrating IL‐17‐producing γδ T cells support the progression of tumor by promoting angiogenesis(2010)233 cited
- → IL-6–dependent spontaneous proliferation is required for the induction of colitogenic IL-17–producing CD8+ T cells(2008)164 cited
- → The critical role of type‐1 innate and acquired immunity in tumor immunotherapy(2004)145 cited
- → Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation(2019)128 cited
- → Anti‐IL‐6 receptor mAb eliminates myeloid‐derived suppressor cells and inhibits tumor growth by enhancing T‐cell responses(2012)125 cited
- → Liposome-Encapsulated CpG Oligodeoxynucleotides as a Potent Adjuvant for Inducing Type 1 Innate Immunity(2004)122 cited
- → Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease–Associated Abdominal Aortic Aneurysm(2016)113 cited
- → 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells(2010)108 cited
- → IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model(2015)97 cited